These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 23497788)
21. An fMRI study examining effects of acute D-cycloserine during symptom provocation in spider phobia. Aupperle RL; Hale LR; Chambers RJ; Cain SE; Barth FX; Sharp SC; Denney DR; Savage CR CNS Spectr; 2009 Oct; 14(10):556-71. PubMed ID: 20095368 [TBL] [Abstract][Full Text] [Related]
22. Cue exposure and response prevention with heavy smokers: a laboratory-based randomised placebo-controlled trial examining the effects of D-cycloserine on cue reactivity and attentional bias. Kamboj SK; Joye A; Das RK; Gibson AJ; Morgan CJ; Curran HV Psychopharmacology (Berl); 2012 May; 221(2):273-84. PubMed ID: 22101394 [TBL] [Abstract][Full Text] [Related]
23. D-Cycloserine acts via increasing the GluN1 protein expressions in the frontal cortex and decreases the avoidance and risk assessment behaviors in a rat traumatic stress model. Sarıdoğan GE; Aykaç A; Cabadak H; Cerit C; Çalışkan M; Gören MZ Behav Brain Res; 2015 Oct; 293():227-33. PubMed ID: 26225843 [TBL] [Abstract][Full Text] [Related]
24. Effects of D-cycloserine on craving to alcohol cues in problem drinkers: preliminary findings. Hofmann SG; Hüweler R; MacKillop J; Kantak KM Am J Drug Alcohol Abuse; 2012 Jan; 38(1):101-7. PubMed ID: 21851195 [TBL] [Abstract][Full Text] [Related]
25. Modeling Causal Relationship Between Brain Regions Within the Drug-Cue Processing Network in Chronic Cocaine Smokers. Ray S; Haney M; Hanson C; Biswal B; Hanson SJ Neuropsychopharmacology; 2015 Dec; 40(13):2960-8. PubMed ID: 26038158 [TBL] [Abstract][Full Text] [Related]
27. Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy. Farrell LJ; Waters AM; Boschen MJ; Hattingh L; McConnell H; Milliner EL; Collings N; Zimmer-Gembeck M; Shelton D; Ollendick TH; Testa C; Storch EA Depress Anxiety; 2013 Aug; 30(8):723-31. PubMed ID: 23722990 [TBL] [Abstract][Full Text] [Related]
28. History of withdrawal modulates drug- and food-cue reactivity in cocaine dependent participants. Denomme WJ; Shane MS Drug Alcohol Depend; 2020 Mar; 208():107815. PubMed ID: 31972520 [TBL] [Abstract][Full Text] [Related]
29. Prospective associations between brain activation to cocaine and no-go cues and cocaine relapse. Prisciandaro JJ; Myrick H; Henderson S; McRae-Clark AL; Brady KT Drug Alcohol Depend; 2013 Jul; 131(1-2):44-9. PubMed ID: 23683790 [TBL] [Abstract][Full Text] [Related]
30. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361 [TBL] [Abstract][Full Text] [Related]
31. Valproate treatment and cocaine cue reactivity in cocaine dependent individuals. Reid MS; Thakkar V Drug Alcohol Depend; 2009 Jun; 102(1-3):144-50. PubMed ID: 19375250 [TBL] [Abstract][Full Text] [Related]
32. Nipping cue reactivity in the bud: baclofen prevents limbic activation elicited by subliminal drug cues. Young KA; Franklin TR; Roberts DC; Jagannathan K; Suh JJ; Wetherill RR; Wang Z; Kampman KM; O'Brien CP; Childress AR J Neurosci; 2014 Apr; 34(14):5038-43. PubMed ID: 24695721 [TBL] [Abstract][Full Text] [Related]
33. Methylphenidate attenuates limbic brain inhibition after cocaine-cues exposure in cocaine abusers. Volkow ND; Wang GJ; Tomasi D; Telang F; Fowler JS; Pradhan K; Jayne M; Logan J; Goldstein RZ; Alia-Klein N; Wong C PLoS One; 2010 Jul; 5(7):e11509. PubMed ID: 20634975 [TBL] [Abstract][Full Text] [Related]
34. Cue-induced brain activity changes and relapse in cocaine-dependent patients. Kosten TR; Scanley BE; Tucker KA; Oliveto A; Prince C; Sinha R; Potenza MN; Skudlarski P; Wexler BE Neuropsychopharmacology; 2006 Mar; 31(3):644-50. PubMed ID: 16123763 [TBL] [Abstract][Full Text] [Related]
35. Enhanced cue reactivity and fronto-striatal functional connectivity in cocaine use disorders. Wilcox CE; Teshiba TM; Merideth F; Ling J; Mayer AR Drug Alcohol Depend; 2011 May; 115(1-2):137-44. PubMed ID: 21466926 [TBL] [Abstract][Full Text] [Related]
39. Effects of D-cycloserine on extinction and reinstatement of morphine-induced conditioned place preference. Lu GY; Wu N; Zhang ZL; Ai J; Li J Neurosci Lett; 2011 Oct; 503(3):196-9. PubMed ID: 21889577 [TBL] [Abstract][Full Text] [Related]
40. Cannabis cue-induced brain activation correlates with drug craving in limbic and visual salience regions: preliminary results. Charboneau EJ; Dietrich MS; Park S; Cao A; Watkins TJ; Blackford JU; Benningfield MM; Martin PR; Buchowski MS; Cowan RL Psychiatry Res; 2013 Nov; 214(2):122-31. PubMed ID: 24035535 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]